XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]        
Net sales $ 1,686 $ 1,990 $ 3,448 $ 3,376
Cost of products sold 948 1,124 1,903 1,978
Gross profit 738 866 1,545 1,398
Selling and administrative expenses 280 322 561 598
Advertising costs 191 186 392 351
Research and development costs 31 32 62 61
Loss on divestiture 0 0 118 0
Pension settlement charge 0 171 0 171
Interest expense 22 26 43 47
Other (income) expense, net (23) (7) (45) 5
Earnings before income taxes 237 136 414 165
Income tax expense 43 40 117 44
Net earnings 194 96 297 121
Less: Net earnings attributable to noncontrolling interests 1 3 5 6
Net earnings attributable to Clorox $ 193 $ 93 $ 292 $ 115
Net earnings per share attributable to Clorox        
Basic net earnings per share (in dollars per share) $ 1.55 $ 0.75 $ 2.36 $ 0.93
Diluted net earnings per share (in dollars per share) $ 1.54 $ 0.75 $ 2.34 $ 0.92
Weighted average shares outstanding (in thousands)        
Basic (in shares) 123,766 124,176 123,781 124,075
Diluted (in shares) 124,662 124,620 124,669 124,635
Comprehensive income $ 160 $ 231 $ 271 $ 255
Less: Total comprehensive income attributable to noncontrolling interests 1 3 5 6
Total comprehensive income attributable to Clorox $ 159 $ 228 $ 266 $ 249